Homology and enzymatic requirements of microhomology-dependent alternative end joining

Cell Death and Disease

Volumn 6, Issue 3, 2015, Pages

  Sharma, S ^a   Javadekar, S M ^a   Pandey, M ^a   Srivastava, M ^a   Kumari, R ^a   Raghavan, S C ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; DNA LIGASE; FEN1 PROTEIN, RAT; FLAP ENDONUCLEASE; LIGASE; MRE11A PROTEIN, RAT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PARP1 PROTEIN, RAT; X-RAY REPAIR CROSS COMPLEMENTING PROTEIN 1;

ANIMAL; CELL FREE SYSTEM; DNA END JOINING REPAIR; DNA REPAIR; DOUBLE STRANDED DNA BREAK; GENE TRANSLOCATION; GENETICS; RAT;

ANIMALS; CELL-FREE SYSTEM; DNA BREAKS, DOUBLE-STRANDED; DNA END-JOINING REPAIR; DNA REPAIR; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; FLAP ENDONUCLEASES; LIGASES; POLY(ADP-RIBOSE) POLYMERASES; RATS; TRANSLOCATION, GENETIC;

EID: 84965087141     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/CDDIS.2015.58     Document Type: Article

References (53)

1. Lieber MR. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu Rev Biochem 2010; 79: 181–211.
2. Wyman C, Kanaar R. DNA double-strand break repair: all's well that ends well. Annu Rev Genet 2006; 40: 363–383.
3. Sharma S, Raghavan SC. Nonhomologous DNA end joining in cell-free extracts. J Nucleic Acids 2012; 2010: 1-11.
4. Gostissa M, Alt FW, Chiarle R. Mechanisms that promote and suppress chromosomal translocations in lymphocytes. Annu Rev Immunol 2011; 29: 319–350.
5. Deriano L, Stracker TH, Baker A, Petrini JH, Roth DB. Roles for NBS1 in alternative nonhomologous end-joining of V(D)J recombination intermediates. Mol Cell 2009; 34: 13–25.
6. Simsek D, Jasin M. Alternative end-joining is suppressed by the canonical NHEJ component Xrcc4-ligase IV during chromosomal translocation formation. Nat Struct Mol Biol 2010; 17: 410–416.
7. Guirouilh-Barbat J, Rass E, Plo I, Bertrand P, Lopez BS. Defects in XRCC4 and KU80 differentially affect the joining of distal nonhomologous ends. Proc Natl Acad Sci USA 2007; 104: 20902–20907.
8. Yan CT, Boboila C, Souza EK, Franco S, Hickernell TR, Murphy M et al. IgH class switching and translocations use a robust non-classical end-joining pathway. Nature 2007; 449: 478–483.
9. Zha S, Boboila C, Alt FW. Mre11: roles in DNA repair beyond homologous recombination. Nat Struct Mol Biol 2009; 16: 798–800.
10. Zhu C, Mills KD, Ferguson DO, Lee C, Manis J, Fleming J et al. Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations. Cell 2002; 109: 811–821.
11. Corneo B, Wendland RL, Deriano L, Cui X, Klein IA, Wong SY et al. Rag mutations reveal robust alternative end joining. Nature 2007; 449: 483–487.
12. Dinkelmann M, Spehalski E, Stoneham T, Buis J, Wu Y, Sekiguchi JM et al. Multiple functions of MRN in end-joining pathways during isotype class switching. Nat Struct Mol Biol 2009; 16: 808–813.
13. Rass E, Grabarz A, Plo I, Gautier J, Bertrand P, Lopez BS. Role of Mre11 in chromosomal nonhomologous end joining in mammalian cells. Nat Struct Mol Biol 2009; 16: 819–824.
14. Xie A, Kwok A, Scully R. Role of mammalian Mre11 in classical and alternative nonhomologous end joining. Nat Struct Mol Biol 2009; 16: 814–818.
15. Rahal EA, Henricksen LA, Li Y, Williams RS, Tainer JA, Dixon K. ATM regulates Mre11-dependent DNA end-degradation and microhomology-mediated end joining. Cell Cycle 2010; 9: 2866–2877.
16. Robert I, Dantzer F, Reina-San-Martin B. Parp1 facilitates alternative NHEJ, whereas Parp2 suppresses IgH/c-myc translocations during immunoglobulin class switch recombination. J Exp Med 2009; 206: 1047–1056.
17. Sallmyr A, Tomkinson AE, Rassool FV. Up-regulation of WRN and DNA ligase IIIalpha in chronic myeloid leukemia: consequences for the repair of DNA double-strand breaks. Blood 2008; 112: 1413–1423.
18. Han L, Mao W, Yu K. X-ray repair cross-complementing protein 1 (XRCC1) deficiency enhances class switch recombination and is permissive for alternative end joining. Proc Natl Acad Sci USA 2012; 109: 4604–4608.
19. Boboila C, Jankovic M, Yan CT, Wang JH, Wesemann DR, Zhang T et al. Alternative end-joining catalyzes robust IgH locus deletions and translocations in the combined absence of ligase 4 and Ku70. Proc Natl Acad Sci USA 2010; 107: 3034–3039.
20. Crespan E, Czabany T, Maga G, Hubscher U. Microhomology-mediated DNA strand annealing and elongation by human DNA polymerases lambda and beta on normal and repetitive DNA sequences. Nucleic Acids Res 2012; 40: 5577–5590.
21. Deng SK, Gibb B, de Almeida MJ, Greene EC, Symington LS. RPA antagonizes microhomology-mediated repair of DNA double-strand breaks. Nat Struct Mol Biol 2014; 21: 405–412.
22. Villarreal DD, Lee K, Deem A, Shim EY, Malkova A, Lee SE. Microhomology directs diverse DNA break repair pathways and chromosomal translocations. PLoS Genet 2012; 8: e1003026.
23. Pannunzio NR, Li S, Watanabe G, Lieber MR. Non-homologous end joining often uses microhomology: implications for alternative end joining. DNA Repair 2014; 17: 74–80.
24. Truong LN, Li Y, Shi LZ et al. Microhomology-mediated end joining and homologous recombination share the initial end resection step to repair DNA double-strand breaks in mammalian cells. Proc Natl Acad Sci USA 2013; 110: 7720–7725.
25. Baumann P, West SC. DNA end-joining catalyzed by human cell-free extracts. Proc Natl Acad Sci USA 1998; 95: 14066–14070.
26. Chen X, Zhong S, Zhu X, Dziegielewska B, Ellenberger T, Wilson GM et al. Rational design of human DNA ligase inhibitors that target cellular DNA replication and repair. Cancer Res 2008; 68: 3169–3177.
27. Dupre A, Boyer-Chatenet L, Sattler RM, Modi AP, Lee JH, Nicolette ML et al. A forward chemical genetic screen reveals an inhibitor of the Mre11-Rad50-Nbs1 complex. Nat Chem Biol 2008; 4: 119–125.
28. Nussenzweig A, Nussenzweig MC. Origin of chromosomal translocations in lymphoid cancer. Cell 2010; 141: 27–38.
29. Nambiar M, Raghavan SC. How does DNA break during chromosomal translocations? Nucleic Acids Res 2011; 39: 5813–5825.
30. Bennardo N, Cheng A, Huang N, Stark JM. Alternative-NHEJ is a mechanistically distinct pathway of mammalian chromosome break repair. PLoS Genet 2008; 4: e1000110.
31. Sharma S, Choudhary B, Raghavan SC. Efficiency of nonhomologous DNA end joining varies among somatic tissues, despite similarity in mechanism. Cell Mol Life Sci 2011; 68: 661–676.
32. Kabotyanski EB, Gomelsky L, Han JO, Stamato TD, Roth DB. Double-strand break repair in Ku86-and XRCC4-deficient cells. Nucleic Acids Res 1998; 26: 5333–5342.
33. Wang H, Perrault AR, Takeda Y, Qin W, Iliakis G. Biochemical evidence for Ku-independent backup pathways of NHEJ. Nucleic Acids Res 2003; 31: 5377–5388.
34. Wang M, Wu W, Rosidi B, Zhang L, Wang H, Iliakis G. PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways. Nucleic Acids Res 2006; 34: 6170–6182.
35. Wang H, Rosidi B, Perrault R, Wang M, Zhang L, Windhofer F et al. DNA ligase III as a candidate component of backup pathways of nonhomologous end joining. Cancer Res 2005; 65: 4020–4030.
36. Brunet E, Simsek D, Tomishima M, DeKelver R, Choi VM, Gregory P et al. Chromosomal translocations induced at specified loci in human stem cells. Proc Natl Acad Sci USA 2009; 106: 10620–10625.
37. Nambiar M, Raghavan SC. Prevalence and analysis of t(14;18) and t(11;14) chromosomal translocations in healthy Indian population. Ann Hematol 2010; 89: 35–43.
38. Summers KE, Goff LK, Wilson AG, Gupta RK, Lister TA, Fitzgibbon J. Frequency of the Bcl-2/ IgH rearrangement in normal individuals: implications for the monitoring of disease in patients with follicular lymphoma. J Clin Oncol 2001; 19: 420–424.
39. Brassesco MS, Camparoto ML, Tone LG, Sakamoto-Hojo ET. Analysis of ETV6/RUNX1 fusions for evaluating the late effects of cancer therapy in ALL (acute lymphoblastic leukemia) cured patients. Cytogenet Genome Res 2004; 104: 346–351.
40. Janz S, Potter M, Rabkin CS. Lymphoma-and leukemia-associated chromosomal translocations in healthy individuals. Genes Chromosomes Cancer 2003; 36: 211–223.
41. Schuler F, Hirt C, Dolken G. Chromosomal translocation t(14;18) in healthy individuals. Semin Cancer Biol 2003; 13: 203–209.
42. Nambiar M, Raghavan SC. Chromosomal translocations among the healthy human population: implications in oncogenesis. Cell Mol Life Sci 2013; 70: 1381–1392.
43. Della-Maria J, Zhou Y, Tsai MS, Kuhnlein J, Carney JP, Paull TT et al. hMre11/hRad50/Nbs1 and DNA ligase III{alpha}/XRCC1 act together in an alternative non-homologous end joining pathway. J Biol Chem 286: 33845–33853.
44. Audebert M, Salles B, Calsou P. Involvement of poly(ADP-ribose) polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA double-strand breaks rejoining. J Biol Chem 2004; 279: 55117–55126.
45. Kumar TS, Kari V, Choudhary B, Nambiar M, Akila TS, Raghavan SC. Anti-apoptotic protein BCL2 down-regulates DNA end joining in cancer cells. J Biol Chem 2010; 285: 32657–32670.
46. Nambiar M, Goldsmith G, Moorthy BT, Lieber MR, Joshi MV, Choudhary B et al. Formation of a G-quadruplex at the BCL2 major breakpoint region of the t(14;18) translocation in follicular lymphoma. Nucleic Acids Res 2011; 39: 936–948.
47. Sathees CR, Raman MJ. Mouse testicular extracts process DNA double-strand breaks efficiently by DNA end-to-end joining. Mutat Res 1999; 433: 1–13.
48. Nambiar M, Raghavan SC. Mechanism of fragility at BCL2 gene minor breakpoint cluster region during t(14;18) chromosomal translocation. J Biol Chem 2012; 287: 8688–8701.
49. Srivastava M, Nambiar M, Sharma S, Karki SS, Goldsmith G, Hegde M et al. An inhibitor of nonhomologous end-joining abrogates double-strand break repair and impedes cancer progression. Cell 2012; 151: 1474–1487.
50. Kavitha CV, Nambiar M, Ananda Kumar CS, Choudhary B, Muniyappa K, Rangappa KS et al. Novel derivatives of spirohydantoin induce growth inhibition followed by apoptosis in leukemia cells. Biochem Pharmacol 2009; 77: 348–363.
51. Chiruvella KK, Sebastian R, Sharma S, Karande AA, Choudhary B, Raghavan SC. Time-dependent predominance of nonhomologous DNA end-joining pathways during embryonic development in mice. J Mol Biol 2012; 417: 197–211.
52. Gunn A, Stark JM. I-SceI-based assays to examine distinct repair outcomes of mammalian chromosomal double strand breaks. Methods Mol Biol 2012; 920: 379–391.
53. Chiruvella KK, Kari V, Choudhary B, Nambiar M, Ghanta RG, Raghavan SC. Methyl angolensate, a natural tetranortriterpenoid induces intrinsic apoptotic pathway in leukemic cells. FEBS Lett 2008; 582: 4066–4076.